Anti ALPP CAR-T cells treatment
Sponsors
TCRCure Biopharma Ltd., Haifeng Qin
Conditions
Recurrent or Metastatic Solid Tumors With Positive ALPPSolid Tumor
Early Phase 1
Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
TerminatedNCT07108140
Start: 2025-05-20End: 2026-01-16Updated: 2026-01-22
Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
TerminatedNCT07123493
Start: 2025-08-28End: 2025-12-30Updated: 2026-01-28